Abbott Laboratories Stock - Chart focus as shares test support

Abbott Laboratories shares recently slipped toward key support levels on the NYSE. On Thursday we take a closer, purely descriptive look at the chart picture and volatility of the healthcare group’s stock, without making forecasts or recommendations.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 14:30 UTC. Details in the imprint.

Abbott Laboratories (US0028241000) is trading noticeably below its 2026 starting level, putting the stock’s medium-term chart picture in focus. On Thursday we look at where the shares currently stand against key support and resistance levels on the NYSE.

What recent trading shows

According to recent quote data, Abbott Laboratories shares lately traded around the high-$80s on the NYSE, after having started 2026 at roughly $125 per share. This implies a decline of close to 30% year-to-date, a notable underperformance for a large healthcare name.

On one of the latest trading days the stock moved in a range roughly between $87.90 and $91.60, indicating intraday volatility of about 4% between low and high. Turnover in the shares ran in the mid single-digit million range, consistent with a liquid Standard & Poor's 500 index constituent.

The chart and technical picture

From a medium-term perspective, Abbott Laboratories shares are trading well below their early-2026 level, which places the current quote in a technically corrective phase rather than near recent highs. The stock has given back a sizable portion of earlier gains, which puts the focus on support zones.

Recent price action shows the shares testing an area in the high-$80s that traders often view as a short-term support zone, after declines from levels above $120 at the beginning of the year. Against this backdrop, market participants will be watching whether that band holds or whether the chart establishes lower trading ranges.

How the company makes its money

Abbott Laboratories generates revenue as a diversified healthcare group with four main segments: diagnostics, medical devices, nutrition products and established pharmaceuticals. Its portfolio includes blood glucose monitoring systems such as the FreeStyle Libre franchise as well as a broad range of cardiovascular and diagnostic devices.

Where the stock trades today

Abbott Laboratories shares (US0028241000) trade on the NYSE at approximately $88.60 as of 06/18/2026, 14:15 UTC.

Abbott Laboratories at a glance

• Company: Abbott Laboratories Inc.
• ISIN: US0028241000
• WKN: 850103
• Ticker: ABT
• Venue: NYSE
• Price (as of 06/18/2026, 14:15 UTC): 88.60 USD
• Market cap: 154,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Health Care / Health Care Equipment & Supplies
• Index membership: Standard & Poor's 500 index
• Next earnings date: 07/17/2026

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.